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Introduction
Achieving high free electron concentrations in germanium is critical for the fabrication of next generation, CMOS integrated microelectronic and optoelectronic devices such as lasers and MOSFETs [1] , [2] . However, for high chemical concentrations of incorporated donors, saturation of the free carrier concentration, in the mid 10 19 cm -3 range, is generally observed for a wide range of doping methods [3] - [9] and it is widely accepted that this is due to binding of the donors to point defects to form donor-vacancy (DnVm) complexes [10] , [11, p.] , [12] . These complexes transform substitutional donors into donor compensating multi-acceptors [13] - [16] which leads to an incomplete activation of the implanted donors. Multiple strategies have been proposed to overcome this issue with some, albeit limited, success [17] , [18] . One possible approach that has not been fully explored is the co-implantation of fluorine and donors, with the explicit intention of leveraging the high electronegativity of fluorine to preferentially complex with vacancies present in the material, thus neutralizing their effect on the donors [19] . Density Functional Theory (DFT) calculations [20] indicate that the binding energy of a fluorine-vacancy (FV) complex is significantly higher than the DV complexes, whilst the formation of fluorinedonor complexes are considered highly unlikely (in contrast with the case of nitrogen [21] and carbon co-doping [22] ). This approach is therefore expected to significantly improve the donor electrical activity through both reduced DV complex formation and retarded diffusivity (donor diffusion is vacancy-assisted). However, in spite of previous efforts [23] - [28] , practical implementation of this has not yet been realized because of the efficient out-diffusion of the fluorine, mediated by the Solid Phase Epitaxy (SPE) during high temperature treatments following implantation [26] . SPE is the phenomenon by which crystallinity is recovered (and donors are properly incorporated at substitutional lattice sites) after the (amorphizing) coimplantation of donors and fluorine. The issue is that the fluorine tends to segregate at the amorphous/crystalline interface during this regrowth [26] and is effectively 'pushed' out of the material. There are essentially two ways to try to circumvent this; i) by employing a sub-second solidification technique, i.e. using pulsed laser annealing (the dynamics of conventional Rapid Thermal Annealing (RTA) are insufficient in achieving this) to increase the recrystallization rate well beyond that of the fluorine diffusion at the re-growth front [29] , or ii) by avoiding SPE altogether through the use of a non-amorphizing implant [19] , which is the approach explored in this contribution. We examine two different non-amorphizing implant schemes that can circumvent this issue and, in doing so, we are able to decouple the fluorine profiles from the SPE and instead show that they are governed by the distribution of point defects in the material.
Ion beam induced amorphization occurs when the number of point defects introduced by the implantation exceeds a certain threshold, the Critical Point Defect Density [30] , (3x10 21 cm -3 for Ge [31] ). The number of vacancy type defects introduced by ion implantation of a target substrate with a particular species can be estimated using the Stopping and Range of Ions in Matter (SRIM) Monte-Carlo simulation program [32] . For shallow implants and fluorine doses sufficient to obtain concentrations of ~10 19 cm -3 , amorphization always occurs for 'regular' implant conditions (i.e. single dose delivery at room temperature). However, we describe two novel approaches to achieve high concentrations of fluorine without amorphizing the germanium: 1) via consecutive, low dose fluorine implants, intertwined with RTA, which partially suppresses cumulative damage 'build-up' (we refer to this as "intertwined" implantation), or 2) by implanting into a 'hot' (200 o C) wafer, which has the effect of increasing the dynamic annealing of the Frenkel pairs resulting in a lower rate of vacancy defect generation [33] (we refer to this as "hot wafer" implantation) [19] .
Experimental
For both techniques, initial sample preparation was identical; thin germanium layers were grown epitaxially on a p-type silicon wafer by Ultra High Vacuum Chemical Vapor Deposition (UHVCVD), using a two-step method described previously [34] . The germanium was then capped by a 30 nm layer of CVD grown SiO2, which is a standard technique for minimizing donor out-diffusion during annealing. We then employ a 900 keV, 10 14 cm -2 dose germanium (self-) pre-amorphization implant (PAI), giving a projected range, RP = 440 nm. This step has been found to provide a systematic improvement in the final free carrier concentration, via differential Hall measurements (not shown here). The samples were then implanted with phosphorus at 200 keV to a dose of 5x10 15 cm -2 , which gives a projected range, RP = 160 nm below the Ge/oxide interface with a peak phosphorus concentration close to the solid solubility limit of 2x10 20 cm -3 [35] . This was followed with a single RTA cycle at 600°C for 2 s (preceded by a 25 s ramp-up from room temperature and followed by a 260 s cool-down to 100°C after lamp switch off) to recover their crystallinity by SPE. Finally, we incorporated the different "intertwined" or "hot wafer" fluorine implants. The intertwined samples were implanted with fluorine in steps of 5x10 13 cm -2 with 2s, 600 o C RTA between each step. For the hot wafer sample the fluorine implant was conducted with the wafer heated to 200°C, followed by a 2s, 600 o C RTA to remove implantation damage. During the hot wafer implants, for the fluorine implanted dose of 4x10 14 ions cm -2 , the dose rate was 3x10 11 ions.cm -2 .s -1 , taking 21 minutes to complete and for the implanted dose of 1x10 15 ions cm -2 , the dose rate was 5x10 11 ions.cm -2 .s -1 , taking 32 minutes to complete. We examined the effects of both different cumulative concentrations of fluorine and implant energy; either 120 keV to match the phosphorus projected range (160nm) or 150 keV to give a peak concentration of fluorine at 200 nm, i.e. just beyond the phosphorus implant peak. XTEM micrographs (not shown here) revealed that the sample crystallinity was preserved after the fluorine implantation using both methods. Control samples were also prepared from the same germanium and phosphorus implants, without fluorine, and employing single cycle RTA at 600 o C for 2 s.
In order to separate any chemical effect of fluorine retention via complex formation with phosphorus (i.e. formation of fluorine-donor complexes), from that of defect passivation by fluorine (i.e. through FV complex formation), we also examined the retained fluorine fraction in samples pre-implanted with nitric oxide (NO) dimers (instead of phosphorus). The NO dimer has a similar mass to phosphorus and thus yields similar implantation damage, whilst having different chemical properties.
Results
The fluorine profiles after a final RTA (2s, 600°C) anneal, shown in Figure 1 , are atypical.
Despite the non-amorphizing nature of the implants and hence absence of SPE regrowth during annealing, we note that the level of fluorine retention is still below 10% (as calculated from the SIMS profiles), indicative of strong out-diffusion. Furthermore, three features from all the SIMS profiles are striking; the profile asymmetry, a relative independence of the profile on implantation energy, and a non-linear increase of the concentration with implanted dose. These properties of the fluorine profiles are a consequence of the low solubility of this element in crystalline germanium, and evidence the fact that the solubility of fluorine is mediated by point defects, as we will show. In the case of standard, isotropic diffusion, chemical profiles broaden symmetrically. The asymmetry of the fluorine profiles observed here shows that the fluorine spread is anisotropic, concentrated in the region between the surface and the implantation peak position (i.e. in the first 200 nm, where the implantation damage is highest). The origin of this asymmetry can either be due to a diffusion gradient or a solubility gradient between the high quality crystalline phase (beyond 200 nm) and the defective phase closer to the surface. In addition to the high level of fluorine outgassing to the implanted surface, we also observed that a significant fraction of the fluorine had diffused throughout the germanium epitaxial layer, towards the rear interface with the silicon substrate, as shown in Figure 5 , and discussed in a later section of this contribution. Given the dynamics of the annealing, this suggests an exceptionally large diffusivity even in the pristine crystalline phase, and indicates that the observed profile asymmetry is rather the result of a large solubility difference. Because it is most soluble in defective regions, the fluorine distribution tracks the point defect distribution, whose asymmetry is of course due to the asymmetry of the implantation: most defects are generated between the surface and the implantation peaks, no defect is generated past the end-of-range. implantation typically yields much wider profiles with lower peak concentrations as the energy for a given implanted species increases). We attribute this implant energy (or depth) insensitivity to the fact that, due to its high diffusivity, fluorine quickly goes where it is most soluble, i.e. regions with higher defect concentrations, which effectively attract and 'pin' the fluorine. This is the case around the phosphorus implantation peak. Indeed, correlation of a high concentration of vacancy defects with high concentrations of implanted donors, generally, explains the incomplete electrical activation of the donors that is often reported for concentrations in excess of ~5x10 19 cm -3 , through a self-compensation mechanism. We rule out the possibility that fluorine is forming complexes with the phosphorus however because the highly asymmetric fluorine profiles differ significantly from the more symmetric phosphorus profiles, as confirmed The presence of F also impacts the P distribution. The difference in the P profiles between the hot wafer samples and the control wafer in Figure 3 is only partly due to their thermal budget.
By design, the hot wafer samples have all undergone a higher thermal budget than the control wafer (two RTA cycles at 600°C versus one for the control wafer, in addition to the 200°C treatment during the fluorine implant), which implies that the phosphorus profile should be broader in the hot wafer than in the control sample. This was the case for the samples implanted with the lowest dose of fluorine (4x10 14 cm -2 ). However, at the implantation peak for the highest dose of fluorine (10 15 cm -2 ), the pinching of the phosphorus distribution (Figure 3) suggests that the phosphorus diffusion is suppressed, where the fluorine concentration is the highest, and that this effect counters the higher thermal budget. We interpret it as the fact that the fluorine dose of 10 15 cm -2 is sufficient to passivate a large fraction of the vacancy population around the implantation peak such that fewer vacancies participate in DV complex formation, which would normally enhance phosphorus diffusion (and ultimately lead to higher loss). There appears therefore to be a threshold fluorine dose effect beyond which the passivation of a sufficiently large fraction of vacancies suppresses the most effective phosphorus diffusion pathway. The dark elongated regions correspond to point defects that remain after the SPE, and are more numerous in the intertwined sample. The 100 nm wide horizontal shadows are artefacts of the diffraction conditions (g = (220)). In these two samples, nitric oxide (NO) dimers were incorporated instead of phosphorus (with identical energy, dose and RTA conditions) prior to the non-amorphizing fluorine implants. The NO dimer has a similar mass to phosphorus and thus approximately yields similar implantation damage, whilst having different chemical properties.
In particular, theoretical [36] , [37] and experimental [21] , [22] , [38] studies have shown that they readily complex with vacancies; their presence results in more defective layers after the SPE.
The implantation energy of fluorine in these samples is 120 keV (same as that in Figure 1 ), but the dose is lower, at 2x10 14 cm -2 . The retained fluorine concentration (post-RTA) is higher in these more defective samples (52% for the "intertwined", 15% for the "hot wafer") than in those pre-implanted with phosphorus (10%). This is because the O and N have indeed stabilized point defects during the SPE: this confirms further that the F solubility is point defect mediated.
Furthermore, despite similar as-implanted profiles, the post-RTA fluorine distributions in these two samples vary widely between the intertwined and the hot wafer sample, because of different initial point defect concentrations. As expected, the micrograph shows that the most defective sample (the intertwined) also has the highest retention of fluorine. Note that it is the opposite of what we observed in P implanted germanium, in which the highest retention was in the hot wafer samples. We speculate that it is because an intertwined implantation generates more defects during implantation (the lower temperature of the substrate yields a lower dynamic annealing), but undergoes a higher thermal budget than a hot wafer implantation (it receives multiple RTAs) and therefore also has a more efficient defect removal after implantation. Because O and N reacts strongly with defects, they stabilize them, and less defects are removed during the RTA than when the more weakly reacting P is present in the sample. As a result, the balance between defect generation and defect removal is different in samples pre-implanted by P or NO dimers, and the net result seems to be more defects in a hot wafer sample for the former, and in an intertwined wafer for the latter.
The low solubility of fluorine is associated with a high diffusivity. Figure 5 shows the fluorine distribution through the whole germanium epi-layer, after a fluorine intertwined implantation (120 keV, 2x10 14 cm -2 ) in the NO-dimer pre-implanted sample (as per Figure 4) , for both asimplanted and post-RTA (2s, 600°C). We find that while the fluorine concentration is reduced post-RTA in the implanted region (first 200 nm) it increases in the buffer layer at the rear (germanium/silicon) interface. This region is known to contain a high misfit type defect concentration, which results from the lattice and thermal expansion mismatch between silicon and germanium. This suggests that the fluorine undergoes extremely long distance diffusion, with a diffusivity determined to be around 10 -9 cm 2 s -1 (at 600°C). This value is consistent with estimations from [39] , which yield diffusivities of 10 -15 cm 2 s -1 at 400°C and > 10 -13 cm 2 s -1 at 500°C. In addition, the concentration of fluorine between 400 nm and 800 nm (where there is no implantation damage, nor misfit dislocations) is below the sensitivity level of our SIMS measurements (~3x10 16 cm -3 ), further confirming that fluorine has minimal solubility in high quality crystalline germanium. Regarding the interaction between fluorine and phosphorus, we have shown earlier (Error! Reference source not found.3) that a concentration of fluorine at the upper 10 18 cm -3 levels can effectively retard the donor diffusion by passivating vacancies. Despite this, Spreading Resistance Analyses (SRA) have not shown any significant change in the free electron concentration in the implanted region by co-doping with fluorine, as shown in Figure 6 . However, this may not be surprising because the highest concentration of retained fluorine we have been able to achieve, post-RTA, remains below 10 19 cm -3 in samples pre-implanted with phosphorus; too low to affect the electrical activation of 10 20 cm -3 phosphorus [19] . We have observed that the presence of fluorine at these levels does result in a significant (order of magnitude) decrease of the free hole concentration in the non-implanted regions of the layer, which indicates an electrical compensating effect, consistent with previous work [40] . Given that the p-type character (10 16 holes cm -3 ) of the as-grown, un-doped Ge-on-Si layer arises as a result of growth related dislocations, our data indicates that such defects can be effectively passivated by the fluorine. If it can be achieved, increasing the fluorine concentrations in these materials further can provide the opportunity to modify the free carrier concentration in donor co-doped layers. 
Conclusions
We have implemented two novel, non-amorphizing implantation methods to achieve and retain relatively high concentrations of fluorine in germanium; by intertwining low dose implants with RTA, or by implanting directly into a hot wafer, and following with a final RTA. The solubility of fluorine in high quality crystalline germanium is low and mediated by point defects. We find that fluorine exhibits an extremely high diffusivity (10 -9 cm 2 s -1 at 600°C) in this material and that it can suppress donor diffusion in defective regions through a preferential association with vacancies, without forming complexes with the incorporated donors. The fact that the solubility of fluorine appears to be a strong function of the remnant point defect concentration (postannealing) means that its retention in sufficiently high concentrations (>10 19 cm -3 ) to affect the electrical activation in highly doped n-type germanium is difficult. However, its high diffusivity and affinity with point defects can be leveraged to decorate specific point defects (in lower concentrations) and spreading defects, such as dislocations associated with growth on lattice mismatched substrates, such as silicon. This can be achieved through long diffusion pathways during relatively short RTA cycles after implanting fluorine outside the active regions of a device, effectively decoupling the implantation from the passivated region. 
